Nick, youre skinny as heck
The retatrutide + tesamorelin + MOTS-C combination appears in research-community searches because it joins three different ideas: incretin signaling, the GH axis, and mitochondrial signaling
Rybelsus should be used with caution in patients with severe kidney dysfunction Semaglutide should not be used in individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC) or in those with Multiple Endocrine Neoplasia syndrome type 2
Saxenda is approved for: Adults Adults with obesity (BMI of 30 kg/m or greater) Adults who are overweight (BMI of 27 kg/m or greater) and have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol Children aged 12 and older Adolescents with obesity who weigh more than 60 kg (132 pounds) Limitations of use Saxenda should not be used together with other medicines that contain liraglutide, such as Victoza, or with any other GLP-1 receptor agonist, such as Ozempic, Wegovy, or Trulicity The safety and effectiveness of Saxenda in children aged 12 to 17 years who have type 2 diabetes have not been established